Additionally, although both autoreactive CD4+ T cells and autoreactive CD8+ T cells are present in MS patients, those patients with relapsing–remitting MS showed a higher proportion of these autoreactive CD8+ T cells [186]. Here, CD8A is linked to myeloid sarcoma.